copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
The Vertical Group - The Company For more than 40 years, the principals of The Vertical Group have been founders, early stage investors, major shareholders, and executives of many of the medical technology industry's most successful companies The Vertical Group is the successor to the venture capital division of F Eberstadt Co , and has been an independent firm since 1988
Who we are - The Vertical Group The Vertical Group is the successor to the venture capital division of F Eberstadt Co , and has been an independent firm since 1988 The Vertical Group is headquartered in Basking Ridge, New Jersey, and has an office in San Mateo, California
Current Portfolio - The Vertical Group The Vertical Group was the lead investor in Tepha at the time of its spin-off from its sister company, Metabolix, Inc Richard B Emmitt and Edward M Giles are members of Tepha's Board of Directors
Meet the Partners - The Vertical Group Prior to his affiliation with The Vertical Group in 1992, Mr Runnells was a cofounder of Paddington Partners, a firm engaged in special situation investing, including public health care equities Prior to that time, Mr Runnells was a partner with the law firm of Webster Sheffield
Our Approach - The Vertical Group The unifying principle underlying The Vertical Group's investment activities remains the ability to leverage the medical device industry knowledge and experience of the firm's general partners
Historic Portfolio - The Vertical Group Vertical was a shareholder of Lifecell from 2001 until the Company’s acquisition by KCI in 2008 for approximately $1 8 billion During its seven years as a shareholder, Vertical assisted Lifecell in establishing corporate partnerships with several Vertical portfolio companies
Our Team - The Vertical Group Mr Slattery is a financial executive with over thirty years of experience He has been a financial officer for public and private companies for over eighteen years, including serving as the CFO of a publicly traded financial services company engaged in asset management, investment banking, stock brokerage, and life insurance
Metabolix Raises $2 Million in Amendment to . . . - vertical-group. com CAMBRIDGE, Mass , May 18, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc (NASDAQ:MBLX) announced today that it has entered into an amendment to its license agreement with Tepha, Inc , a Lexington, Massachusetts based medical device company that licenses Metabolix PHA biopolymer technology for use in certain medical applications
The Vertical Group - News Luminopia, Inc , a commercial-stage company pioneering a new class of treatments for neuro-visual disorders, today announced that the company’s lead product, Luminopia, was named one of TIME’s Best Inventions of 2023